MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » ConforMIS sues Acacia Research over disingenuous access to confidential docs

ConforMIS sues Acacia Research over disingenuous access to confidential docs

By

ConforMIS logo

Medical device maker ConforMIS filed a counter-suit against a patent holder and a patent management firm, claiming the pair used disingenuous means to acquire information in support of an infringement case against the company.

Massachusetts-based ConforMIS claimed that Acacia Research, acting on behalf of client and inventor Peter Bonutti, access the company’s online Surgeon Resource Center and other corporate portals in order to gather ammunition for a patent infringement lawsuit over knee arthroplasty methods.

Acacia Research engineering vice president Phillip Mitchell allegedly logged onto the ConforMIS websites and accessed confidential business documents just days before filing a lawsuit accusing ConforMIS and its iUni G2 Unicompartmental Knee Resurfacing System of patent infringement, ConforMIS claimed.

In May 2012 Mitchell allegedly accessed a ConforMIS site that required him to agree to certain terms of use, including that the information was not for use by any parties with competing interests, according to the complaint.

ConforMIS claimed that Mitchell logged in under the guise of an authorized entity and used information gathered there to encourage Bonutti and his holding company to file a patent infringement lawsuit.

The device maker contacted Mitchell on June 7, 2012, to revoke his log-in credentials and note the violation of the terms of use. One day later, Bonutti’s holding company assigned the arthroplasty patent to Acacia Research. The patent was handed down to subsidiary Advanced skeletal, which then handed it over to Bonutti Skeletal.

About 3 months later, Bonutti Skeletal filed a lawsuit against ConforMIS in the U.S. District Court for the District of Delaware, according to the complaint.

ConforMIS is asking a judge to deem the iUni knee device non-infringing on the Bonutti patent and to further nullify the patent entirely. The company would also like a judgment against Mitchell for breach of contract and misappropriation of confidential information over the allegedly violated terms of use for the company’s online portal.

ConforMIS is further calling for a judgment of unfair and deceptive trade practices by Acacia Research, according to legal documents.

In case you missed it

RSS From Medical Design & Outsourcing

  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]
  • Blue Spark’s TempTraq catches fevers faster. Fever prediction is next.
    Blue Spark Technologies developed the first wireless continuous temperature monitor patch, TempTraq, to enable faster fever detection than standard manual readings every four hours. Westlake, Ohio-based Blue Spark is now looking at fever prediction rather than just detecting them. The R&D team is working on developing an AI neural network model built on the company’s… […]
  • Harvard researchers plan to sell at-home, PCR-grade COVID testing system
    The Harvard University researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to commercialize it as a portable COVID-19 test. Harvard Medical School professor Peng Yin, who also leads the Wyss Institute for Biologically Inspired Engineering’s Molecular Robotics Initiative, founded 3EO Health to sell the device. “In order to optimize the value of… […]
  • FDA reports sterilization challenge progress as EPA takes aim at EtO emissions
    The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. facilities where use of ethylene oxide (EtO) presents a risk to communities. The FDA said it is similarly concerned about unsafe EtO emissions and highlighted work with the medical device industry to reduce EtO usage… […]
  • AdvaMed defends EtO facilities on EPA’s cancer risk list
    The Advanced Medical Technology Association (AdvaMed) today reacted to the EPA’s listing of commercial sterilization facilities causing elevated risks of cancer with a defense of the facilities and a call for more research. AdvaMed CEO and President Scott Whitaker said all of the listed facilities are in compliance with regulations and warned against closures. “The… […]

Leave a Reply